Brightsurf Science News and Current Science News Events
 

HPV News | HPV Current Events

Sort By: Page Views | Date
Merck investigational vaccine GARDASIL prevented 100 percent of cervical pre- & non-invasive cancers
Merck & Co., Inc., prevented 100 percent of high-grade cervical pre-cancers and non-invasive cervical cancers (CIN 2/3 and AIS) associated with human papillomavirus (HPV) types 16 and 18 in a new phase III study.   view more (2005-10-07)

Tattooing improves response to DNA vaccine
A tattoo can be more than just a fashion statement - it has potential medical value, according to an article published in the online open access journal, Genetic Vaccines and Therapy.   view more (2008-02-07)

New screen-and-treat methods for cervical cancer significantly reduce cancer precursor lesions
A new study led by Columbia University Medical Center researchers demonstrates the safety and efficacy of two low-tech diagnostic tools to significantly reduce the prevalence of cervical cancer precursor lesions.   view more (2005-11-03)

Study: Harmless virus kills some cancers
Six days is all it takes for a common, non-disease-causing virus to kill cervical, breast, prostate and squamous cell cancer cells in laboratory cultures, according to Penn State College of Medicine researchers.   view more (2005-06-22)

Updated data on novel HPV vaccine confirms efficacy in large population
Updated data from a study on a promising new vaccine against a pre-cancerous cervical virus shows superior efficacy in preventing cervical pre-cancers and non-invasive cervical cancer.   view more (2005-11-01)

Parents need to be educated about HPV vaccinations for daughters
Parents of young girls may soon be offered the opportunity to have their daughters immunised against a sexually transmitted virus that is the major cause of cervical cancer, the 4th International Conference on Teenage and Young Adult Cancer Medicine heard today.   view more (2006-03-30)

Higher risk for cervical cancer seen among women infected with multiple HPV types
The risk for developing the tissue abnormalities, or lesions, that typically precede cervical cancer is much higher for women infected with multiple genotypes of the human papillomavirus (HPV) than previously reported.   view more (2006-07-11)

Brisbane teens receive first cancer vaccine shots
UQ Professor Ian Frazer administered the first shots of the cervical cancer vaccine Gardasil in Queensland this afternoon at the Princess Alexandra Hospital.   view more (2006-08-29)

Painkillers may threaten power of vaccines
With flu-shot season in full swing and widespread anticipation of the HPV vaccine to prevent cervical cancer, a new University of Rochester study suggests that using common painkillers around the time of vaccination might not be a good idea.   view more (2006-11-29)

HPV testing finds precancerous lesions at a higher rate than conventional pap smears
Human papillomavirus (HPV) testing was more sensitive than traditional Pap smears at detecting precancerous lesions of the cervix.   view more (2006-06-07)

HPV infection linked to throat cancers
Researchers at the Johns Hopkins Kimmel Cancer Center have conclusive evidence that human papillomavirus (HPV) causes some throat cancers in both men and women.   view more (2007-05-10)

What does the public really know about HPV?
Human papillomaviruses (HPV) are the most common sexually transmitted infections in the United States, and certain "high risk" types have been shown to cause cervical cancer.   view more (2006-11-13)

HPV testing a cost-effective strategy for women with equivocal cervical screening results
A new study has found that using human papillomavirus (HPV) DNA testing to determine who should receive a cervical examination called colposcopy is a cost-effective management strategy for women with equivocal Pap test results known as ASCUS (atypical squamous cells of undetermined significance).   view more (2006-01-18)

How cow warts, clergy sex surveys moved along cancer vaccine
The creation of a successful vaccine against cervical cancer, approved today by the U.S. Food and Drug Administration, is the culmination of research that occurred thanks not only to scientists and physicians, but also to generous farmers and veterinarians, priests and nuns willing to tell all... view more (2006-06-12)

High HPV concentrations combined with smoking significantly raise risks of cervical cancer
Cigarette smoking and concurrent infection with high levels of the virus associated with cervical cancer can increase cancer risk by as much as 27 times, according to a study published in the November 2006 issue of Cancer Epidemiology, Biomarkers & Prevention.   view more (2006-11-17)

A year of added life more valuable for the young, study suggests
Many important health policy issues, such as the allocation of avian flu vaccine in a pandemic or mandatory HPV vaccinations for young women, require policy makers to decide healthcare priorities for different age groups.   view more (2007-03-08)

HIV drug could be used to prevent cervical cancer, say University of Manchester researchers
Researchers at the University of Manchester are developing a topical treatment against the human papilloma virus (HPV) which is responsible for pre-cancerous and cancerous disease of the cervix as well as other genital malignancies.   view more (2006-08-25)

Human Papilloma virus as a predictor of cervical cancer
Two studies published in this week's issue of THE LANCET suggest that the detection of the amount of human papillomavirus (HPV) could help identify women at risk of cervical cancer. Infection with certain types of HPV - which is common among young women - increases the risk of cervical cancer.... view more (2000-06-22)

Immune deficiency linked to a type of eye cancer
The incidence of squamous cell eye cancer is greater among kidney transplant patients and people with human immunodeficiency virus (HIV) than the general public, which suggests the disease is associated with immune deficiency.   view more (2007-08-15)

HPV infection common among females in US
Data from a national study suggests that about one in four U.S. females between the ages of 14 and 59 years may have the sexually transmitted infection human papillomarivus (HPV), according to a study in the February 28 issue of JAMA.   view more (2007-02-28)

HPV test is a better long-term predictor of cervical cell abnormalities than pap smear
The best initial cervical cancer screening tool for younger women is still the traditional Pap smear. However, a large Danish study has found that for older women (age 40 and older), a test for human papillomavirus (HPV) is a much more effective way to screen for potential cancer.   view more (2006-11-01)

Antibody signal may redirect inflammation to fuel cancer
As evidence mounts that the body's normally protective inflammation response can drive some precancerous tissues to become fully malignant, UCSF scientists report discovering an apparent trigger to this potentially deadly process.   view more (2007-02-20)

Research To Improve Screening For Warts Linked To Cervical Cancer Risk
Researchers are testing thousands of cervical smear samples to try and identify which types of wart viruses may lead to cancer. They will also examine the benefits of a new form of smear testing. Collaborating scientists and doctors from the University of Edinburgh, Lothian University Hospitals... view more (2002-04-24)

Temple University Hospital investigates treatment for cervical dysplasia
Temple University Hospital's Center For Women's Health is participating in a national study to determine the safety and effectiveness of an investigational treatment for cervical dysplasia.   view more (2007-01-31)

Girls born with HIV infection at higher risk for cervical problems
A generation of children born with HIV are now coming of age and reaching sexual maturity. Girls in this group who are sexually active are experiencing a higher number than expected of cervical abnormalities, a new study finds.   view more (2007-04-27)

Sort By: Page Views | Date
© 2008 BrightSurf.com